Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Net Cash Flow (2021 - 2025)

Historic Net Cash Flow for Kezar Life Sciences (KZR) over the last 5 years, with Q3 2025 value amounting to $4.6 million.

  • Kezar Life Sciences' Net Cash Flow fell 3029.24% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year decrease of 5037.3%. This contributed to the annual value of $6.3 million for FY2024, which is 22737.35% up from last year.
  • As of Q3 2025, Kezar Life Sciences' Net Cash Flow stood at $4.6 million, which was down 3029.24% from -$2.7 million recorded in Q2 2025.
  • In the past 5 years, Kezar Life Sciences' Net Cash Flow ranged from a high of $66.5 million in Q2 2022 and a low of -$40.9 million during Q3 2022
  • In the last 5 years, Kezar Life Sciences' Net Cash Flow had a median value of -$1.6 million in 2023 and averaged $939105.3.
  • Examining YoY changes over the last 5 years, Kezar Life Sciences' Net Cash Flow showed a top increase of 180831.66% in 2022 and a maximum decrease of 151921.94% in 2022.
  • Kezar Life Sciences' Net Cash Flow (Quarter) stood at $5.8 million in 2021, then tumbled by 515.59% to -$24.0 million in 2022, then surged by 137.26% to $9.0 million in 2023, then dropped by 22.23% to $7.0 million in 2024, then tumbled by 34.3% to $4.6 million in 2025.
  • Its Net Cash Flow stands at $4.6 million for Q3 2025, versus -$2.7 million for Q2 2025 and -$4.8 million for Q1 2025.